Produkty 98665-19-1

CAS 98665-19-1 występuje w naszej ofercie pod nazwami: Ganoderic acid H/ 95%, Ganoderic acid H, Ganoderic acid H, ≥98%, ≥98%, Ganoderic acid H, 99.25%. Oferty producentów: TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 2mg, 1 mg, 5 mg.

Ganoderic acid H/ 95%
TargetMol
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 1754,02
Zobacz produkt
Ganoderic acid H
Biosynth
  • opakowanie: 1mg, 2mg
  • Warianty: 2
Zobacz produkt
Ganoderic acid H, ≥98%, ≥98%
Chemat
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 2267,60
Zobacz produkt
Ganoderic acid H, 99.25%
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 1559,64
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

6-(12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid (CAS 98665-19-1) to związek chemiczny o wzorze sumarycznym C32H44O9 i masie molowej 572.7 g/mol. Nazwa systematyczna IUPAC: 6-(12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid. InChIKey: YCXUCEXEMJPDRZ-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC32H44O9
Masa molowa572.7 g/mol
Nazwa IUPAC6-(12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-methyl-4-oxoheptanoic acid
InChIKeyYCXUCEXEMJPDRZ-UHFFFAOYSA-N
SMILESCC(CC(=O)CC(C)C(=O)O)C1CC(=O)C2(C1(C(C(=O)C3=C2C(=O)CC4C3(CCC(C4(C)C)O)C)OC(=O)C)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Ganoderic acid H, Ganoderic Acid H [M+H]+, orb1684591, YCXUCEXEMJPDRZ-UHFFFAOYSA-N, 12-Acetoxy-3-hydroxy-7,11,15,23-tetraoxolanost-8-en-26-oic acid, 3beta-Hydroxy-7,11,15,23-tetraoxo-12beta-acetoxy-5alpha-lanost-8-en-26-oic acid
Izomery (ten sam wzór sumaryczny)
(E,4S,6R)-6-[(3S,5R,10S,12S,13R,14R,17R)-12-acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-7,11,15-trioxo-1,2,3,5,6,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-4-hydroxy-2-methylhept-2-enoic acid C32H44O9
8-[[(3S,5R,8R,9S,10S,11S,13R,14S,17R)-11,14-dihydroxy-10,13-dimethyl-12-oxo-17-(6-oxopyran-3-yl)-2,3,4,5,6,7,8,9,11,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-8-oxooctanoic acid C32H44O9
(Z,2R)-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-12-acetyloxy-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid C32H44O9
(6R)-6-[(5R,7S,10S,12S,13R,14R,17R)-12-acetyloxy-7-hydroxy-4,4,10,13,14-pentamethyl-3,11,15-trioxo-1,2,5,6,7,12,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid C32H44O9
(E)-6-[(3S,5R,7S,10S,12S,13R,14R,17R)-12-acetyloxy-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxohept-5-enoic acid C32H44O9